Overview Dividends

(XHR) Xenia Hotels & Resorts - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9840171030

Luxury Hotels, Upscale Resorts, Hotel Portfolio, Rooms

Hotel & Resort REITs
Market Cap in USD: 1,522m

IPO / Inception: 2015-02-04
Return 12m vs S&P 500: -10.8%

EPS (Earnings per Share)

EPS CAGR: 84.42%
EPS Trend: 25.3%

Last SUE: 0.17
Qual. Beats: 0

Revenue

Rev. CAGR: 4.07%
Rev. Trend: 44.4%

Last SUE: 0.10
Qual. Beats: 0

Dividends

Dividend Yield	4.54%
Yield on Cost 5y	5.33%
Yield CAGR 5y	14.94%
Payout Consistency	74.1%
Payout Ratio	84.0%

Risk via 5d forecast
Volatility	26.8%
Value at Risk 5%th	39.8%
Relative Tail Risk	-9.81%

Reward TTM
Sharpe Ratio	0.16
Alpha	-19.12
CAGR/Max DD	0.19

Character TTM
Hurst Exponent	0.694
Beta	1.258
Beta Downside	1.284

Drawdowns 3y
Max DD	42.47%
Mean DD	12.79%
Median DD	12.04%

Description: XHR Xenia Hotels & Resorts November 13, 2025

Xenia Hotels & Resorts, Inc. (NYSE:XHR) is a self-advised, self-administered REIT that concentrates on luxury and upper-upscale hotels and resorts located in the top 25 U.S. lodging markets and premier leisure destinations. The portfolio comprises 30 properties, totaling 8,868 rooms across 14 states, and is operated or licensed by major brands such as Marriott, Hyatt, Fairmont, Kimpton, Loews, Hilton, and The Kessler Collection.

As of Q3 2024, Xenia’s average occupancy hovered around 71%, with a RevPAR growth of 4.2% year-over-year, reflecting the rebound in discretionary travel and strong demand for upscale accommodations. The REIT’s weighted-average ADR sits near $210, benefitting from a 6% annual increase in corporate travel budgets and a robust leisure-to-business travel mix. Forward-looking, the sector remains sensitive to macro-drivers like consumer confidence, inflation-adjusted discretionary spending, and the trajectory of the Federal Reserve’s interest-rate policy, which directly impacts cap-rate compression and refinancing risk.

For a deeper dive into XHR’s valuation metrics and scenario analysis, you might find ValueRay’s interactive dashboards useful.

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (56.4m TTM) > 0 and > 6% of Revenue (6% = 64.5m TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA 2.27pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 15.46% (prev 12.36%; Δ 3.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 185.7m > Net Income 56.4m (YES >=105%, WARN >=100%)

Net Debt (1.23b) to EBITDA (234.0m) ratio: 5.28 <= 3.0 (WARN <= 3.5)

Current Ratio 2.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (95.2m) change vs 12m ago -6.55% (target <= -2.0% for YES)

Gross Margin 22.18% (prev 24.49%; Δ -2.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 37.24% (prev 35.48%; Δ 1.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.21 (EBITDA TTM 234.0m / Interest Expense TTM 84.9m) >= 6 (WARN >= 3)

Altman Z'' -0.56

(A) 0.06 = (Total Current Assets 299.3m - Total Current Liabilities 133.2m) / Total Assets 2.87b

(B) -0.23 = Retained Earnings (Balance) -663.6m / Total Assets 2.87b

(D) -0.40 = Book Value of Equity -662.4m / Total Liabilities 1.64b

Total Rating: -0.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 54.47

1. Piotroski 4.50pt

2. FCF Yield 3.29%

3. FCF Margin 8.43%

4. Debt/Equity 1.21

5. Debt/Ebitda 5.28

6. ROIC - WACC (= -2.46)%

7. RoE 4.65%

8. Rev. Trend 44.39%

9. EPS Trend 25.33%

What is the price of XHR shares?

As of December 22, 2025, the stock is trading at USD 14.98 with a total of 566,051 shares traded.
Over the past week, the price has changed by +0.81%, over one month by +7.61%, over three months by +4.77% and over the past year by +3.34%.

Is XHR a buy, sell or hold?

Xenia Hotels & Resorts has received a consensus analysts rating of 3.71. Therefor, it is recommend to hold XHR.

Strong Buy: 3
Buy: 1
Hold: 2
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the XHR price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	15.2	1.5%
Analysts Target Price	15.2	1.5%
ValueRay Target Price	15.9	6.4%

XHR Fundamental Data Overview December 21, 2025

Market Cap USD = 1.52b (1.52b USD * 1.0 USD.USD)
P/E Trailing = 26.75
P/E Forward = 63.2911
P/S = 1.4162
P/B = 1.2063
Beta = 1.254
Revenue TTM = 1.07b USD
EBIT TTM = 102.5m USD
EBITDA TTM = 234.0m USD
Long Term Debt = 1.42b USD (from longTermDebt, last quarter)
Short Term Debt = 4.43m USD (from shortTermDebt, last fiscal year)
Debt = 1.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.23b USD (from netDebt column, last quarter)
Enterprise Value = 2.76b USD (1.52b + Debt 1.42b - CCE 188.2m)
Interest Coverage Ratio = 1.21 (Ebit TTM 102.5m / Interest Expense TTM 84.9m)
FCF Yield = 3.29% (FCF TTM 90.6m / Enterprise Value 2.76b)
FCF Margin = 8.43% (FCF TTM 90.6m / Revenue TTM 1.07b)
Net Margin = 5.24% (Net Income TTM 56.4m / Revenue TTM 1.07b)
Gross Margin = 22.18% ((Revenue TTM 1.07b - Cost of Revenue TTM 836.4m) / Revenue TTM)
Gross Margin QoQ = 5.65% (prev 29.27%)
Tobins Q-Ratio = 0.96 (Enterprise Value 2.76b / Total Assets 2.87b)
Interest Expense / Debt = 1.53% (Interest Expense 21.8m / Debt 1.42b)
Taxrate = 4.50% (-684.0k / -15.2m)
NOPAT = 97.9m (EBIT 102.5m * (1 - 4.50%))
Current Ratio = 2.25 (Total Current Assets 299.3m / Total Current Liabilities 133.2m)
Debt / Equity = 1.21 (Debt 1.42b / totalStockholderEquity, last quarter 1.18b)
Debt / EBITDA = 5.28 (Net Debt 1.23b / EBITDA 234.0m)
Debt / FCF = 13.63 (Net Debt 1.23b / FCF TTM 90.6m)
Total Stockholder Equity = 1.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.97% (Net Income 56.4m / Total Assets 2.87b)
RoE = 4.65% (Net Income TTM 56.4m / Total Stockholder Equity 1.21b)
RoCE = 3.89% (EBIT 102.5m / Capital Employed (Equity 1.21b + L.T.Debt 1.42b))
RoIC = 3.75% (NOPAT 97.9m / Invested Capital 2.61b)
WACC = 6.21% (E(1.52b)/V(2.95b) * Re(10.65%) + D(1.42b)/V(2.95b) * Rd(1.53%) * (1-Tc(0.04)))
Discount Rate = 10.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.41%
[DCF Debug] Terminal Value 67.24% ; FCFE base≈64.6m ; Y1≈58.2m ; Y5≈49.9m
Fair Price DCF = 6.36 (DCF Value 602.9m / Shares Outstanding 94.8m; 5y FCF grow -12.43% → 3.0% )
EPS Correlation: 25.33 | EPS CAGR: 84.42% | SUE: 0.17 | # QB: 0
Revenue Correlation: 44.39 | Revenue CAGR: 4.07% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.17 | Chg30d=+0.020 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.27 | Chg30d=+0.035 | Revisions Net=+1 | Growth EPS=+0.0% | Growth Revenue=+3.1%

Additional Sources for XHR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle